LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer

Cyclin D1 is one of the most important oncoproteins that drives cancer cell proliferation and associates with tamoxifen resistance in breast cancer. Here, we identify a lncRNA, DILA1, which interacts with Cyclin D1 and is overexpressed in tamoxifen-resistant breast cancer cells. Mechanistically, DIL...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Nat Commun
Päätekijät: Shi, Qianfeng, Li, Yudong, Li, Shunying, Jin, Liang, Lai, Hongna, Wu, Yanqing, Cai, Zijie, Zhu, Mengdi, Li, Qian, Li, Ying, Wang, Jingru, Liu, Yujie, Wu, Zongqi, Song, Erwei, Liu, Qiang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7608661/
https://ncbi.nlm.nih.gov/pubmed/33139730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-19349-w
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia